• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

What Can Pharma Do for Patients Post IRA?

Article

Kevin Hagan, president and CEO of the PAN Foundation, discusses how pharma can help Medicare patients post-IRA reform.

Kevin Hagan, president and CEO of the PAN Foundation, discusses how pharma can help Medicare patients post-IRA reform. Hagan notes there is a continuing need to have copay assistance because Medicare patients still face a $2K out of pocket cost, which is still a challenge for many of them.

Visit the PAN Foundation's "Everything You Need to Know About Medicare Reforms" for patients, providers and industry.

Recent Videos
Related Content